The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor.
about
Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.The Wilms' tumor gene Wt1 is required for normal development of the retinaIn silico regulatory analysis for exploring human disease progression.Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemiaCommon variants at 11p13 are associated with susceptibility to tuberculosis.Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approachSuppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.WT1 expression in the human fetus during development.CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells.The Incidence of and Factors Associated with Vitamin D Deficiency in Newly Diagnosed Children with Cancer.Modulating effects of WT1 on interferon-β-vitamin D association in MS.Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms.Effective treatment of leukemic cell lines with wt1 siRNA.Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells.
P2860
Q28507412-B4853D86-BDA1-42DD-85B6-5A6793201E00Q28590668-4275D239-581C-4BB5-8CF4-2578EE121A57Q30482686-B09807A0-67EE-4579-98EE-EC75639E62CFQ33680919-761A49AA-6D68-4D34-A6A3-AE54D02D2C5BQ34252123-984B6A1C-1D8F-4744-A0B1-E0A7A0AF8156Q35134342-1C569769-B9BE-4CA8-81F1-F39E49147C4DQ35646945-6AAD04F1-591A-47AA-9E7F-49DA569BF5FBQ35856457-F617A5D2-52F7-4311-BCFD-49650E4147FBQ37075299-AA9B8AEF-7D09-42FB-99F4-4761ABE13E1DQ38857203-A5227FEA-4ECE-42A3-BB3F-E06A3E4521C9Q39129087-6A53F4A0-AE8E-4EBF-A178-AEEDBD55FCBAQ39686531-C2A8FBC5-A887-4CF1-AAA5-83C1C21EB555Q40095623-874640D2-7ABC-413B-B674-E6FA721F98A1Q40759660-CAF6F09C-F0E9-4CFA-A781-1A8EC0379D6DQ47388677-44579BB1-F5F1-49EE-AEE4-F9A1D0EB8F74
P2860
The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@ast
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@en
type
label
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@ast
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@en
prefLabel
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@ast
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@en
P2093
P2860
P356
P1476
The Wilms' tumor gene product ...... ion of the vitamin D receptor.
@en
P2093
Bergmann L
Hubinger G
Weidmann E
P2860
P304
P356
10.1074/JBC.M005292200
P407
P577
2000-10-24T00:00:00Z